R C Inhorn

2.0k total citations
24 papers, 1.7k citations indexed

About

R C Inhorn is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, R C Inhorn has authored 24 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Molecular Biology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in R C Inhorn's work include Cancer Treatment and Pharmacology (7 papers), Retinoids in leukemia and cellular processes (4 papers) and Cell Adhesion Molecules Research (4 papers). R C Inhorn is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Retinoids in leukemia and cellular processes (4 papers) and Cell Adhesion Molecules Research (4 papers). R C Inhorn collaborates with scholars based in United States and Germany. R C Inhorn's co-authors include Philip W. Majerus, Vinay S. Bansal, James D. Griffin, Matthias Eder, Noriko Sato, Frederick W. Quelle, Atsushi Miyajima, Bruce A. Witthuhn, James N. Ihle and Thomas Connolly and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

R C Inhorn

24 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R C Inhorn United States	16	828	509	464	224	193	24	1.7k
Daniel J. Price United States	22	1.9k 2.3×	369 0.7×	257 0.6×	108 0.5×	315 1.6×	31	2.4k
Christian Chabert Switzerland	20	1.8k 2.2×	374 0.7×	528 1.1×	92 0.4×	283 1.5×	22	2.5k
Elizabeth M. Deacon United Kingdom	14	900 1.1×	607 1.2×	424 0.9×	65 0.3×	129 0.7×	15	1.8k
Pascale F. Dijkers Netherlands	15	2.3k 2.8×	526 1.0×	538 1.2×	104 0.5×	224 1.2×	16	2.9k
Corine Gilliéron Switzerland	14	1.9k 2.3×	424 0.8×	605 1.3×	85 0.4×	291 1.5×	15	2.6k
Guofu Fang United States	18	1.4k 1.6×	384 0.8×	171 0.4×	367 1.6×	285 1.5×	22	2.1k
Bruno Cenni Switzerland	22	1.1k 1.4×	751 1.5×	189 0.4×	155 0.7×	42 0.2×	35	2.4k
Michele A. Glozak United States	14	2.4k 2.9×	682 1.3×	257 0.6×	188 0.8×	77 0.4×	18	2.9k
Kim U. Birkenkamp Netherlands	13	979 1.2×	255 0.5×	255 0.5×	130 0.6×	89 0.5×	14	1.4k

Countries citing papers authored by R C Inhorn

Since Specialization

Citations

This map shows the geographic impact of R C Inhorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R C Inhorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R C Inhorn more than expected).

Fields of papers citing papers by R C Inhorn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R C Inhorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R C Inhorn. The network helps show where R C Inhorn may publish in the future.

Co-authorship network of co-authors of R C Inhorn

This figure shows the co-authorship network connecting the top 25 collaborators of R C Inhorn. A scholar is included among the top collaborators of R C Inhorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R C Inhorn. R C Inhorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Inhorn, R C, Davey B. Daniel, Cassie M. Lane, et al.. (2009). Correlation of SPARC, ER, PR, and HER2 tumor with progression-free survival from a phase II neoadjuvant trial of gemcitabine, epirubicin, and nab-paclitaxel. Journal of Clinical Oncology. 27(15_suppl). 618–618. 4 indexed citations

Yardley, DA, et al.. (2009). Preliminary progression free survival and SPARC tumor correlatives from a phase II neoadjuvant trial of gemcitabine, epirubicin, and nab paclitaxel.. Cancer Research. 69(2_Supplement). 5116–5116. 1 indexed citations

Raefsky, Eric, R C Inhorn, Marie Lange, et al.. (2009). Preliminary safety results from a multicenter phase II trial of nanoparticle albumin-bound paclitaxel/cyclophosphamide in early stage breast cancer plus trastuzumab in HER-2+ patients (pts). Journal of Clinical Oncology. 27(15_suppl). e11509–e11509. 1 indexed citations

Daniel, Davey B., R C Inhorn, Lisa Simons, et al.. (2008). Safety and feasibility of biweekly neoadjuvant gemcitabine, epirubicin, and albumin bound nab-paclitaxel (GEA) in locally advanced breast cancer – results of a phase II study. European Journal of Cancer Supplements. 6(7). 119–120. 1 indexed citations

Spigel, David R., John D. Hainsworth, Charles Webb, et al.. (2008). Phase II trial of gemcitabine, docetaxel, and cetuximab in advanced non-small-cell lung cancer (NSCLC). Journal of Clinical Oncology. 26(15_suppl). 19045–19045. 1 indexed citations

Yardley, Denise A., R C Inhorn, Davey B. Daniel, et al.. (2008). Phase II study of neoadjuvant gemcitabine, epirubicin, and albumin-bound nab paclitaxel (GEA) in locally advanced breast cancer with SPARC tumor assessments. Journal of Clinical Oncology. 26(15_suppl). 603–603. 2 indexed citations

Durstin, M, R C Inhorn, & J D Griffin. (1996). Tyrosine phosphorylation of Shc is not required for proliferation or viability signaling by granulocyte-macrophage colony-stimulating factor in hematopoietic cell lines. The Journal of Immunology. 157(2). 534–540. 36 indexed citations

Mukhopadhyay, Nishit K., R C Inhorn, Dwayne L. Barber, et al.. (1996). The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a p21ras-dependent manner.. Proceedings of the National Academy of Sciences. 93(21). 11681–11686. 77 indexed citations

Inhorn, R C, Nadia Carlesso, M Durstin, David A. Frank, & J D Griffin. (1995). Identification of a viability domain in the granulocyte/macrophage colony-stimulating factor receptor beta-chain involving tyrosine-750.. Proceedings of the National Academy of Sciences. 92(19). 8665–8669. 50 indexed citations

10.

Matsuguchi, Tetsuya, R C Inhorn, Nadia Carlesso, et al.. (1995). Tyrosine phosphorylation of p95Vav in myeloid cells is regulated by GM-CSF, IL-3 and steel factor and is constitutively increased by p210BCR/ABL.. The EMBO Journal. 14(2). 257–265. 130 indexed citations

11.

Quelle, Frederick W., Noriko Sato, Bruce A. Witthuhn, et al.. (1994). JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region.. Molecular and Cellular Biology. 14(7). 4335–4341. 434 indexed citations

12.

Eder, Matthias, T J Ernst, Arnold Ganser, et al.. (1994). A low affinity chimeric human alpha/beta-granulocyte-macrophage colony-stimulating factor receptor induces ligand-dependent proliferation in a murine cell line.. Journal of Biological Chemistry. 269(48). 30173–30180. 45 indexed citations

13.

McGuire, Elizabeth A., et al.. (1988). Phosphorylation of vitronectin by a protein kinase in human plasma. Identification of a unique phosphorylation site in the heparin-binding domain.. Journal of Biological Chemistry. 263(4). 1942–1945. 38 indexed citations

14.

Majerus, Philip W., Thomas Connolly, Vinay S. Bansal, et al.. (1988). Inositol phosphates: synthesis and degradation.. Journal of Biological Chemistry. 263(7). 3051–3054. 316 indexed citations

15.

Inhorn, R C & Philip W. Majerus. (1988). Properties of inositol polyphosphate 1-phosphatase.. Journal of Biological Chemistry. 263(28). 14559–14565. 80 indexed citations

16.

Bansal, Vinay S., R C Inhorn, & Philip W. Majerus. (1987). The metabolism of inositol 1,3,4-trisphosphate to inositol 1,3-bisphosphate.. Journal of Biological Chemistry. 262(20). 9444–9447. 69 indexed citations

17.

Inhorn, R C, Vinay S. Bansal, & Philip W. Majerus. (1987). Pathway for inositol 1,3,4-trisphosphate and 1,4-bisphosphate metabolism.. Proceedings of the National Academy of Sciences. 84(8). 2170–2174. 99 indexed citations

18.

Inhorn, R C & Philip W. Majerus. (1987). Inositol polyphosphate 1-phosphatase from calf brain. Purification and inhibition by Li+, Ca2+, and Mn2+.. Journal of Biological Chemistry. 262(33). 15946–15952. 111 indexed citations

19.

Zile, Maija H., R C Inhorn, & Hector F. DeLuca. (1982). Metabolism in vivo of all-trans-retinoic acid. Biosynthesis of 13-cis-retinoic acid and all-trans- and 13-cis-retinoyl glucuronides in the intestinal mucosa of the rat.. Journal of Biological Chemistry. 257(7). 3544–3550. 60 indexed citations

20.

Zile, Maija H., R C Inhorn, & Hector F. DeLuca. (1980). The Biological Activity of 5,6-Epoxyretinoic Acid. Journal of Nutrition. 110(11). 2225–2230. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact